Chen et al. show that candesartan (Cand) displays an antioxidant action independent of angiotensin type 1 receptor (AT1R) blockade that translates into a superior renoprotection of chronic renal inflammation. The peculiarity of Cand in combining AT1R-blocking activity and an antioxidant action could have important theoretical implications for therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/ki.2008.420 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!